← All Sponsors
SPONSOR

IDP Discovery Pharma S.L.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Multiple Myeloma (MM)Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble Hit LymphomaHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedChronic Lymphocytic Leukemia (CLL)Triple Hit Lymphoma
NCT05908409 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Multiple Myeloma (MM)
Spain View Trial →